Reduction of Trauma-induced Intrusions and Amygdala Hyperreactivity Via Non-invasive Brain Stimulation

NCT ID: NCT04325087

Last Updated: 2020-03-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-07-01

Study Completion Date

2020-05-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study will focus on the modulation of intrusive memories via functional magnetic resonance imaging (fMRI)-guided repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex (dlPFC) directly after exposure to a traumatic video.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Traumatic experiences can lead to posttraumatic stress disorder (PTSD) with clinical manifestations including intrusions, avoidance behavior, and hyperarousal. Unlike most other psychological disorders, a PTSD diagnosis requires a clearly identifiable inciting event. As such, preventive interventions in recently traumatized individuals seem promising.

In this randomized, placebo-controlled study the investigators explore the potential of individualized transcranial magnetic stimulation (TMS) to reduce trauma-induced intrusive thoughts by altering functional connectivity between the dorsolateral prefrontal cortex (dlPFC) and amygdala. Subjects will undergo a functional magnetic resonance imaging (fMRI) session consisting of a resting state scan, an emotion recognition task and an anatomical scan at the beginning of the study (day 1). Resting state data will be used to determine individualized TMS targets for every subject, depending on functional connectivity between the dlPFC and amygdala. Subsequently, the analogue trauma model will be used to induce intrusions in healthy subjects. Subjects will be confronted with a video clip from the movie "Irreversible" and they will complete online questionnaires in the following three days to measure intrusive thoughts, trauma disclosure (i.e. duration of conversations about the aversive movie) and sleeping quality. Intermittent theta-burst stimulation (iTBS) will be administered directly after the video clip and on the following two days (day 2-4). Cognitive tasks will be applied before and after iTBS sessions to examine short-term effects of iTBS on a behavioral level. Finally, subjects will undergo a second fMRI session similar to the first one, to probe iTBS-induced changes in functional connectivity and emotional processing (day 5).

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intrusive Thoughts Post Traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Participants receive either three sessions of iTBS over the dorsolateral prefrontal cortex or three sessions of a placebo stimulation.
Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Active iTBS

Active stimulation of the dlPFC directly after trauma exposure and on the following two days

Group Type EXPERIMENTAL

iTBS

Intervention Type DEVICE

Administration of an iTBS protocol over the dlPFC

Placebo iTBS

Same procedure as in the active stimulation group but with a placebo stimulation imitating the sensation of a real iTBS protocol.

Group Type PLACEBO_COMPARATOR

Placebo iTBS

Intervention Type DEVICE

Administration of a placebo TMS protocol over the dlPFC

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

iTBS

Administration of an iTBS protocol over the dlPFC

Intervention Type DEVICE

Placebo iTBS

Administration of a placebo TMS protocol over the dlPFC

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Healthy subjects

Exclusion Criteria

* current psychiatric illness
* current psychiatric medication or psychotherapy
* past PTSD diagnosis
* MRI contraindication (e.g. metal in body, claustrophobia)
* pregnancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Bonn

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rene Hurlemann

Professor Rene Hurlemann, M.Sc., M.D., Ph.D.

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Rene Hurlemann, MSc, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Oldenburg

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Psychiatry, University of Bonn

Bonn, , Germany

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Germany

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Dirk Scheele, PhD

Role: CONTACT

+49 (0)228 287 ext. 11151

Mitjan Morr, MSc

Role: CONTACT

+49 (0)228 287 ext. 19578

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dirk Scheele, PhD

Role: primary

+49 (0)228 287 ext. 11151

Mitjan Morr, MSc

Role: backup

+49 (0)228 287 ext. 19578

Related Links

Access external resources that provide additional context or updates about the study.

http://renehurlemann.squarespace.com/welcome/

Neuromodulation of Emotion (NEMO) research group

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COOL

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.